Aneuploidy is a prominent phenotype of cancer. It refers to deviations from the normal number of chromosomes in a cell, as a result of whole-chromosome loss or gain. In most cases, aneuploidy is caused by mitotic errors. Unlike DNA damage, once a cell becomes aneuploid, there is almost no way to correct the lost or the gained chromosomes. This cell and its descendants will remain aneuploid and the aneuploidy may worsen if the cell loses or gains chromosomes again in subsequent mitoses. As aneuploidy alters the genome in a large scale, one must ask: do cells mount a response to it? Our previous work demonstrated that aneuploidy could activate p53 and cause apoptotic cell death. We showed that the activation of p53 depended on the ATM kinase which was activated by the elevated levels of reactive oxygen species (ROS) in aneuploid cells. These results suggest the existence of an aneuploidy checkpoint that limits the transformation potential of an aneuploid cell. Intriguingly, aneuploidy seems to preferentially activate p53-mediated apoptosis, instead of senescence. On the other hand, when p53 is inactivated, aneuploidy induces robust senescence and p16 expression. Thus, the aneuploidy checkpoint prevents the proliferation of aneuploid cells by induce p53- mediated cell death and senescence when the p53 pathway fails.
Our specific aims are: 1) to elucidate how aneuploidy activates p53-mediated apoptosis;2) to determine how aneuploidy induces senescence in the absence of p53;and 3) to demonstrate that the induction of the senescence program plays a role in preventing aneuploidy-induced tumorigenesis.

Public Health Relevance

We will carry out experiments designed to understand how aneuploidy checkpoint operates to prevent tumorigenesis. The goals of this grant are to elucidate the mechanisms that cause p53-mediated apoptosis and p16-dependent senescence in aneuploid cells.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Molecular Oncogenesis Study Section (MONC)
Program Officer
Mietz, Judy
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Schools of Medicine
United States
Zip Code
Hatcher, Rashieda J; Dong, Jie; Liu, Shuang et al. (2014) Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis. Proc Natl Acad Sci U S A 111:1008-13
O'Hara, Laura; York, Jean Philippe; Zhang, Pumin et al. (2014) Targeting of GFP-Cre to the mouse Cyp11a1 locus both drives cre recombinase expression in steroidogenic cells and permits generation of Cyp11a1 knock out mice. PLoS One 9:e84541
Fan, Yihui; Mao, Renfang; Yu, Yang et al. (2014) USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J Exp Med 211:313-28
Zhang, Wei; Peng, Guang; Lin, Shiaw-Yih et al. (2011) DNA damage response is suppressed by the high cyclin-dependent kinase 1 activity in mitotic mammalian cells. J Biol Chem 286:35899-905
Wei, Zhubo; Peddibhotla, Sirisha; Lin, Han et al. (2011) Early-onset aging and defective DNA damage response in Cdc14b-deficient mice. Mol Cell Biol 31:1470-7
Fang, Xiao; Zhang, Pumin (2011) Aneuploidy and tumorigenesis. Semin Cell Dev Biol 22:595-601
Peddibhotla, Sirisha; Wei, Zhubo; Papineni, Rao et al. (2011) The DNA damage effector Chk1 kinase regulates Cdc14B nucleolar shuttling during cell cycle progression. Cell Cycle 10:671-9
Liang, Yulong; Gao, Hong; Lin, Shiaw-Yih et al. (2010) BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice. PLoS Genet 6:e1000826
Gao, Xue; Shin, Yong-Hyun; Li, Min et al. (2010) The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS One 5:e14005
Li, Min; Fang, Xiao; Baker, Darren J et al. (2010) The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci U S A 107:14188-93

Showing the most recent 10 out of 14 publications